Breathe BioMedical — Investor Overview

BBM

Breathe BioMedical Inc.

Non-invasive breath test for early breast cancer detection — Moncton, NB & Cambridge, MA

🫁 MedTech 🔬 Diagnostics ♋ Oncology Moncton, NB Clinical Stage

🫁

The Breath Test

A non-invasive breath-based test targeting the 50% of cancers mammography misses in dense breast tissue — no radiation, no compression.

🏥

Multi-Center Trials

9 clinical sites across the US and Canada — including IWK Health NS, Mayo Clinic, Duke University, and GWU — enrolling 800 subjects.

📈

Clear Commercialization Path

Canadian Lab Developed Test by 2029–30, US FDA-approved product by 2032. Revenue via test fees, licensing, M&A, and partnerships.

>99%

5-year survival rate when caught at Stage I

<32%

5-year survival rate at Stage IV — the cost of missing it

50%

of cancers mammography misses in dense breast tissue

Company Details

StageClinical Trials
HQMoncton, NB
Also InCambridge, MA
SectorMedTech / Oncology
PilotASCO 2023
Websitebreathebiomedical.com

Leadership Team

CEOBill Dawes
CMODr. Rachel Brem

Clinical Sites

GWUActive 6/2025
Duke UniversityActive 8/2025
Mayo ClinicActive 1/2026
IWK Health, NSActive 9/2026
Horizon Health NBActive 10/2026

📄 What's in the Investor Overview

Enter your details below to unlock the full investment deck prepared by the Breathe BioMedical team.

📊 Market size & opportunity

💰 Raise details & use of funds

🔬 Clinical trial data & protocol

🎯 Commercialization roadmap

🔓 Unlock the Investor Overview

Enter your details below to access the Breathe BioMedical investor deck. For accredited investors and interested parties only.

First Name *

Last Name *

Email Address *

Organization / Fund (optional)

I consent to receiving occasional updates and investment opportunities from North Founders. Unsubscribe anytime. (Privacy Policy)

I consent to Breathe BioMedical contacting me with information relevant to this investment opportunity.

✅ I have read and understood the disclaimer below and confirm any investment decision I make will be based on my own independent due diligence. (Required)

🔒 Your information is secure and will never be sold.

✅

You're in. Here's the deck.

A copy has also been sent to your email. Welcome to the North Founders investor network.

⬇️ Download Breathe BioMedical Investor Deck

📧 Also sent to your inbox — check spam if you don't see it within a few minutes.

⚠️ Important Disclaimer — Please Read

The information on this page and in the accompanying document is provided by North Founders for informational purposes only and does not constitute financial, investment, legal, or tax advice.

North Founders is not a registered investment dealer, broker-dealer, or investment adviser. Nothing herein should be construed as a recommendation, solicitation, or offer to buy or sell securities. North Founders does not endorse, recommend, or guarantee the suitability of any investment in Breathe BioMedical Inc. or any other company featured on this platform.

Investing in early-stage companies involves significant risk, including the potential for total loss of capital. Any individual who chooses to invest does so entirely at their own risk, based on their own independent analysis and due diligence. North Founders accepts no liability for any investment decisions made in reliance on this information.

This page is intended for accredited investors and sophisticated parties only under applicable Canadian securities laws. If you have questions about your eligibility to invest, consult a qualified financial or legal professional.

Detecting breast cancerbefore it's too late.